NCT00928343View on ClinicalTrials.gov

First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy

Interventions

DRUG

GLPG0187

Single ascending subcutaneous doses (subcutaneous solution), and single oral dose (oral solution)

DRUG

Placebo

Matching subcutaneous or oral placebo

Trial Locations (1)

Unknown

SGS Stuivenberg, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY

NCT00928343 - First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187 | Biotech Hunter | Biotech Hunter